Dataset from Continued Efficacy and Safety Monitoring of Solanezumab, an Anti-Amyloid β Antibody in Patients With Alzheimer's Disease

This study is an open-label extension study in Alzheimer's patients who have completed
participation in either solanezumab Clinical Trial H8A-MC-LZAM (NCT00905372) or H8A-MC-LZAN
(NCT00904683).

本研究为一项开放标签扩展试验（open-label extension study），受试者为已完成索拉珠单抗（solanezumab）临床试验H8A-MC-LZAM（NCT00905372）或H8A-MC-LZAN（NCT00904683）的阿尔茨海默病患者。